XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73−0.05 (-2.81%)
Close on Nov 18, 2026Market cap $52.74MP/E –Yield –
XBiotech shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
XBiotech's shares outstanding was 30M at Jun 30, 2026. For fiscal 2025 it was 30M, up 0.1% from the year before. Over ten years it grew -0.1% a year on average. The highest annual figure on record is 46M in fiscal 2019.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30M | +0.1% |
| FY2024 | Dec 31, 2024 | 30M | +0.1% |
| FY2023 | Dec 31, 2023 | 30M | -0.0% |
| FY2022 | Dec 31, 2022 | 30M | +1.3% |
| FY2021 | Dec 31, 2021 | 30M | -2.5% |
| FY2020 | Dec 31, 2020 | 31M | -33.5% |
| FY2019 | Dec 31, 2019 | 46M | +29.4% |
| FY2018 | Dec 31, 2018 | 36M | +2.7% |
| FY2017 | Dec 31, 2017 | 35M | +7.6% |
| FY2016 | Dec 31, 2016 | 32M | +5.2% |
| FY2015 | Dec 31, 2015 | 31M | +27.5% |
| FY2014 | Dec 31, 2014 | 24M | +8.7% |
| FY2013 | Dec 31, 2013 | 22M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 30M | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | 30M | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | 30M | +0.1% |
| Q3 FY2025 | Sep 30, 2025 | 30M | +0.0% |
| Q2 FY2025 | Jun 30, 2025 | 30M | +0.1% |
| Q1 FY2025 | Mar 31, 2025 | 30M | +0.1% |
| Q4 FY2024 | Dec 31, 2024 | 30M | +0.1% |
| Q3 FY2024 | Sep 30, 2024 | 30M | +0.1% |
| Q2 FY2024 | Jun 30, 2024 | 30M | +0.1% |
| Q1 FY2024 | Mar 31, 2024 | 30M | +0.0% |
| Q4 FY2023 | Dec 31, 2023 | 30M | +0.0% |
| Q3 FY2023 | Sep 30, 2023 | 30M | -0.0% |
| Q2 FY2023 | Jun 30, 2023 | 30M | -0.0% |
| Q1 FY2023 | Mar 31, 2023 | 30M | 0.0% |
| Q4 FY2022 | Dec 31, 2022 | 30M | +0.1% |
| Q3 FY2022 | Sep 30, 2022 | 30M | +0.3% |
| Q2 FY2022 | Jun 30, 2022 | 30M | +1.5% |
| Q1 FY2022 | Mar 31, 2022 | 30M | +3.5% |
| Q4 FY2021 | Dec 31, 2021 | 30M | +3.9% |
| Q3 FY2021 | Sep 30, 2021 | 30M | +4.5% |
| Q2 FY2021 | Jun 30, 2021 | 30M | +3.9% |
| Q1 FY2021 | Mar 31, 2021 | 29M | -18.7% |
| Q4 FY2020 | Dec 31, 2020 | 29M | -58.6% |
| Q3 FY2020 | Sep 30, 2020 | 29M | -29.2% |
| Q2 FY2020 | Jun 30, 2020 | 29M | -23.1% |
| Q1 FY2020 | Mar 31, 2020 | 36M | +0.5% |
| Q4 FY2019 | Dec 31, 2019 | 71M | +97.3% |
| Q3 FY2019 | Sep 30, 2019 | 41M | +14.5% |
| Q2 FY2019 | Jun 30, 2019 | 38M | +4.7% |
| Q1 FY2019 | Mar 31, 2019 | 36M | +1.5% |
| Q4 FY2018 | Dec 31, 2018 | 36M | +10.9% |
| Q3 FY2018 | Sep 30, 2018 | 36M | +1.1% |
| Q2 FY2018 | Jun 30, 2018 | 36M | +1.4% |
| Q1 FY2018 | Mar 31, 2018 | 35M | +6.5% |
| Q4 FY2017 | Dec 31, 2017 | 32M | -0.6% |
| Q3 FY2017 | Sep 30, 2017 | 35M | +9.2% |
| Q2 FY2017 | Jun 30, 2017 | 35M | – |
| Q1 FY2017 | Mar 31, 2017 | 33M | – |
| Q4 FY2016 | Dec 31, 2016 | 33M | – |
| Q3 FY2016 | Sep 30, 2016 | 32M | – |
See a number that looks wrong?